JHJeong Ho Hwang

Jeong Ho Hwang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jeong Ho Hwang has a total of 200 co-authors. Here are the top co-authors by number of shared publications:

  • Hoon Taek Lee

    Department of Animal Biotechnology, Bio-Organ Research Center/Animal Resources Research Center, Konkuk University, Seoul, South Korea

    11 shared publications
  • Young Kyu Kim

    Large Animal Convergence Research Center, Korea Institute of Toxicology, Jeongeup, South Korea

    9 shared publications
  • Ju Young Lee

    Center for Large Animals Convergence Research, Korea Institute of Toxicology, Jeongeup, Republic of Korea

    8 shared publications
  • Guneswar Sethi

    Animal Biotechnology and Genomics Division, National Institute of Animal Science, Rural Development Administration Jeonbuk State Republic of Korea

    7 shared publications
  • Mi-Jin Yang

    Korea Institute of Toxicology, Jeongeup, Republic of Korea

    7 shared publications
  • Goo-Hwa Kang

    Division of Jeonbuk Advanced Bio Research, Korea Institute of Toxicology, Jeongeup, Republic of Korea

    6 shared publications

Latest Publications

  • Open Access

    Multi-omic landscape of a porcine SCID model with a single-codon RAG2 deletion

    by Kwonho Hong, Minhee Kang, Kiho Lee, Jeong Ho Hwang, Young Kyu Kim, Bing-Qiang Zhang, Zhuang-Bing Li, Yan-Ni Feng, Xi-Feng Zhang, Jin-Hoi Kim

  • Open Access

    Beyond immune rejection: integrative genetic engineering strategies for overcoming coagulopathy in xenotransplantation

    by Jeong Ho Hwang

    Jeong Ho Hwang. Clin Transplant Res -0001;0:. https://doi.org/10.4285/ctr.26.0044

  • Open Access

    ε-Viniferin Attenuates LPS-Induced Inflammatory Activation in Canine Macrophages by Regulating NF-κB and MAPK Pathways

    by Minseo Cho, Jisu Lee, Hyunsoo Jang, Hyeon-Cheol Cha, Gisol Kim, Jaeho Pyee, Bong-Hyun Kim, Su-Cheol Han, Jeong Ho Hwang, Jung-Heun Ha

  • Open Access

    Discovery of Potent Antimalarial Agents Targeting Plasmodium falciparum DNA Gyrase B by Integrating Computational and Experimental Approaches

    by Biswajit Naik, Welka Sahu, Guneswar Sethi, Cherish Prashar, Gajendra Mohan Baldodiya, Jyoti Poswal, Chandi C. Mandal, Jeong Ho Hwang, Kailash C. Panday, K. Sony Reddy, et al.

    The global spread of drug‐resistant Plasmodium falciparum , particularly artemisinin‐resistant strains, underscores the urgent need for novel antimalarial agents with distinct mechanisms of action and improved therapeutic potential. In this study, we employed an integrated in silico and in vitro strategy to identify compounds with inhibitory activity against P. falciparum apicoplast Gyrase B (PfGyrB). High‐throughput virtual screening identified hit compounds with favorable predicted interactions against the target protein, which were subsequently evaluated using biochemical ATPase inhibition and parasite growth inhibition assays. UNC8153 and Fexofenadine hydrochloride demonstrated time‐dependent antiplasmodial activity, with lower IC 50 values at 96 h than at 48 h under prolonged exposure conditions. UNC8153 exhibited greater antiplasmodial activity (~25‐fold) than the reference compound novobiocin during the second intraerythrocytic cycle. Morphological analysis indicated impaired parasite development during the second intraerythrocytic cycle under prolonged exposure conditions. Importantly, UNC8153 retained inhibitory activity against the artemisinin‐resistant C580Y strain and exhibited minimal cytotoxicity toward HEK‐293 cells under the tested experimental conditions. Structural similarity analysis indicated that the identified compounds are chemically distinct from currently used antimalarial drugs, supporting their structural novelty. Collectively, these findings identify UNC8153 as a structurally distinct new antiplasmodial scaffold warranting further mechanistic, pharmacological, and in vivo evaluation.

  • Open Access

    Freeze-Dried Extracts of Eruca sativa Selectively Inhibit Nuclear Factor-κB and Vascular Endothelial Growth Factor Levels in Retinal Pigment Epithelial Cells

    by Minseo Cho, Jisu Lee, Jiwoo Lee, Caglar Doguer, Jeong Ho Hwang, Jung-Heun Ha

    Diabetic retinopathy and age-related macular degeneration are driven by retinal pigment epithelium (RPE) dysfunction accompanied by chronic inflammation and an upregulation of vascular endothelial growth factor (VEGF). This study investigated the protective effects of Eruca sativa freeze-dried extract against metabolic and inflammatory stress in the ARPE-19 retinal epithelial cell line. Gene expression levels and protein contents were assessed via quantitative real-time polymerase chain reaction and Western blots. VEGF secretion and cell calcium levels were quantified using enzyme-linked immunosorbent assay and Fluo-4 NW calcium assay, respectively. Freeze-dried E. sativa extract (ESF) exposure did not induce any cytotoxicity across the concentration range tested. Under thapsigargin (Tg) stimulation, ESF at 1 mg/mL significantly reduced VEGF expression and protein secretion by 32% and 34%, respectively. Tg-induced calcium mobilization within cells and the expression of unfolded protein response markers, including CCAAT/enhancer-binding protein homologous protein, binding immunoglobulin protein, and X-box binding protein-1, remained unchanged following ESF exposure. Under lipopolysaccharide stimulation, in a dose-dependent manner, ESF suppressed nuclear factor-κB (NF-κB) phosphorylation, tumor necrosis factor-α, and interleukin-1β expression; however, c-Jun N-terminal kinase signaling was not affected. Hot-air-dried E. sativa extract demonstrated contrasting regulatory profiles, which exhibited a broader modulation of endoplasmic reticulum stress and mitogen-activated protein kinase signaling. Collectively, the findings demonstrate that ESF selectively attenuates inflammatory and angiogenic responses by specifically inhibiting the NF-κB-VEGF axis. Dehydration, therefore, is a critical method determining ESF bioactivity, preserving native phytochemicals that confer focused anti-inflammatory and anti-angiogenic efficacy in RPE cells.

  • Open Access

    Characteristics between porcine bone marrow-derived mesenchymal stem and peripheral blood mononuclear cells

    by Young Kyu Kim, Ju Young Lee, Ji Woo Shin, Jeong Ho Hwang

    Journal of Animal Science and Technology (JAST) is a peer-reviewed, open access journal publishing original research, review articles and notes in all fields of animal science. Topics covered by the journal include: genetics and breeding, physiology, nutrition of monogastric animals, nutrition of ruminants, animal products (milk, meat, eggs and their by-products) and their processing, grasslands and roughages, livestock environment, animal biotechnology, animal behavior and welfare.

  • Open Access

    Computational identification of natural inhibitors targeting GroEL in Leptospira interrogans: an integrative virtual screening and molecular dynamics approach

    by Guneswar Sethi, Sthitaprajna Sahoo, Su-Cheol Han, Donghyun Shin, Jeong Ho Hwang

    Introduction: Leptospirosis is a zoonotic disease caused by Leptospira interrogans and represents a major public health and veterinary concern. The persistence of the pathogen is closely associated with biofilm formation, yet targeted therapeutics are currently unavailable. The GroEL chaperonin, a conserved protein involved in biofilm formation and immunogenicity, was investigated as a potential therapeutic target. Methods: A structure-based virtual screening approach was performed using a library of 543,503 natural compounds from the Life Chemicals database. Top-ranked ligands were evaluated using molecular docking and physicochemical and pharmacokinetic property analyses. Density functional theory calculations were performed to assess electronic stability, followed by molecular dynamics simulations to evaluate ligand–protein complex stability. Principal component analysis and MM-PBSA binding free energy calculations were subsequently applied to characterize conformational dynamics and binding affinity. Results: Five compounds (F3385-2019, F1243-0200, F3139-0927, F2801-0179, and F1864-0208) exhibited strong binding affinities toward GroEL, with docking energies ranging from −10.34 to −8.26 kcal/mol. All shortlisted compounds complied with Lipinski’s Rule of Five and demonstrated favorable pharmacokinetic properties. Molecular dynamics simulations and MM-PBSA analyses indicated stable ligand–protein interactions. Among the candidates, F1864–0208 and F1243–0200 emerged as the most stable and promising leads, whereas the remaining compounds showed moderate inhibition. Discussion: This study provides computational evidence supporting GroEL as a viable drug target in L. interrogans . The identified natural compounds may represent promising scaffolds for the development of novel anti-leptospiral agents. Further in vitro and in vivo studies are required to validate their therapeutic efficacy and safety.


  • The effect of alginate on in vitro and in vivo behaviors of ticagrelor self-microemulsifying drug delivery system

    by Yu-Rim Hwang, Young-Guk Na, Minki Jin, Jong-Suep Baek, Yo Han Song, Da-Eun Kim, Suyeon Hwang, Samuel Lee, Young Ju Jo, Hong-Ki Lee, et al.


  • Open Access

    Hemolysis-induced hepatic ferroptosis following xenotransfusion of genetically modified pig red blood cells

    by Ha-Young Shin, Ju Young Lee, Young-Jin Jang, Hyung-Sun Kim, Seon Ryong Park, Goo-Hwa Kang, Joohyun Shim, Nayoung Ko, Jeong Ho Hwang

    To overcome cross-species immunological barriers, researchers utilize gene editing to remove the expression of three major carbohydrate xenoantigens ( α-Gal , Neu5Gc , and Sd(a) ) and insert genes, such as human protective genes ( hCD55 and hCD39 ). This study aimed to investigate the mechanisms underlying long-term hepatic injury following xenotransfusion of genetically modified pig red blood cells (pRBCs). We xenotransfused pRBCs genetically engineered with GGTA1 −/− ( α-Gal −) ; CMAH −/− ( Neu5Gc − ); β4GALNT2 −/− ( Sd(a) − ) ; hCD55; hCD39 into a non-human primate (NHP) model of acute hemorrhage hemolysis and evaluated the long-term immune response to xenogeneic RBCs in the liver, a key organ for RBC metabolism. Immediately after xenotransfusion (D + 1), significant elevations of liver enzymes (AST, ALT) and iron-related factors were observed in the serum levels of the recipients, which were normalized by D + 21. However, long-term analysis revealed excessive accumulation of iron ions in the liver and decreased expression of antioxidant enzymes. The resulting endoplasmic reticulum stress (increased GRP78/BiP expression), lipid peroxide accumulation, and iron-dependent cell death (ferroptosis) persisted in the liver of the recipient. These results suggest that, beyond gene editing, additional hurdles must be overcome to completely block oxidative stress damage caused by impaired RBC lysis. Notably, transcriptomic and immunohistochemical analyses in the NHP model identified the direct role of ferroptosis in xenotransfusion-induced liver injury. Therefore, we propose that a multilayered approach, including blocking the ROS-Iron axis and administering ferroptosis inhibitors, is needed to ensure long-term safety in the clinical development of xenotransfusion.


  • Open Access

    In silico design of a multi-epitope vaccine against Cryptosporidium parvum using structural and immunoinformatics approaches

    by Guneswar Sethi, Avinash Kant Lakra, Kirti Nirmal, Jeong Ho Hwang

    Background: Cryptosporidium parvum is a waterborne protozoan parasite responsible for diarrheal illness in humans and animals. The lack of effective vaccines and the emergence of antimicrobial resistance underscore the urgent need for novel prophylactic strategies. Methods: A structure-based immunoinformatics approach was used to design a multi-epitope subunit vaccine (MESV) targeting immunogenic regions of C. parvum . Three proteins, Cp15, Cp23, and CpP2, were selected based on antigenicity, non-allergenicity, non-homology with host proteins, and absence of transmembrane domains. B-cell, CD4 + , CD8 + , and IFN-γ-inducing epitopes were identified and screened for high antigenicity, non-allergenicity, and non-toxicity. To enhance immune recognition, the lipoprotein LprA, a TLR2 agonist, was fused at the N-terminus using an EAAAK linker, and a PADRE sequence was added to improve helper T-cell responses. Linkers were applied to ensure proper epitope separation and processing. Population coverage was analyzed to evaluate the distribution of HLA-restricted epitopes across global populations. Structural modeling and flexibility analysis (CABS-flex) were performed to assess construct stability. Interactions with TLR2 and TLR4 were examined via molecular docking and 100-ns molecular dynamics (MD) simulations, with MM-GBSA used to estimate binding free energies. Immune simulations predicted host immune responses, while codon optimization, in silico cloning, and mRNA secondary structure prediction assessed expression and transcript stability. Results: The MESV showed strong binding to TLR2 (−1328.4 kcal/mol) and TLR4 (−1133.3 kcal/mol), with MD simulations confirming stable complexes. Immune simulations indicated robust antibody production, T-cell activation, cytokine release, and dendritic cell recruitment. The vaccine demonstrated global HLA population coverage of 95.92%, with favorable expression and mRNA folding profiles. Conclusion: The MESV construct demonstrated strong immunogenicity, structural stability, and broad population coverage, underscoring its potential as a promising vaccine candidate against C. parvum . Furthermore, experimental validation is warranted to confirm its safety and efficacy.